First patient dosed in ulcerative colitis drug trial
Drug Discovery World
MARCH 29, 2023
A Phase I clinical trial has begun evaluating Direct Biologics’ ExoFlo for the treatment of patients with medically refractory ulcerative colitis (UC). The primary objective of the trial is to evaluate the safety of intravenous ExoFlo.
Let's personalize your content